2026-01-11 - Analysis Report
# ğŸ“ˆ KLA Corp (KLAC) Quickâ€‘Take Report

## 0ï¸âƒ£ Basic Snapshot  
- **Ticker**: KLAC  
- **Company**: KLA Corp â€“ a leading semiconductor equipment and services provider.  
- **Cumulative return**: **+200.69â€¯%** (last data point).  
- **S&Pâ€¯500 (VOO) comparison**: **+94.03â€¯%**.  
- **Return divergence**: **+106.7â€¯%** (absolute) â€“ KLAC outperformed the benchmark by 106.7â€¯%.  
- **Relative divergence**: **100.0â€¯%** â€“ KLAC sits at the very top of its historical divergence range (maxâ€¯106.7, minâ€¯â€“15.2).  

### Initial Numbers (before analysis)
- 5â€‘day SMA: **$1,366.35**  
- 20â€‘day SMA: **$1,272.25**  
- 60â€‘day SMA: **$1,207.14**  
- Close: **$1,400.00** (up **$75.40** from previous close, +5.69â€¯%).  
- RSI: **69.85** (near overbought).  
- PPO: **0.82â€¯%** (positive).  
- MRI: **0.70** (Mediumâ€‘Risk).  
- Expected Return: **6.9â€¯%** (longâ€‘term excess vs. S&Pâ€¯500).  

## 1ï¸âƒ£ Alpha & Beta Highlights (2016â€‘2025)  
- **CAGR** swung from **â€‘12â€¯%** (2022â€‘24) to an eyeâ€‘popping **115â€¯%** (2023â€‘25).  
- **MDD** stayed around 25â€‘40â€¯%, peaking at **39.3â€¯%** in 2020â€‘22.  
- **Alpha** improved dramatically from **â€‘2â€¯%** (2016â€‘18) to **+53â€¯%** (2023â€‘25).  
- **Beta** skyrocketed from **11.8** to **160.0**, indicating **high volatility** relative to the market.  

> **Takeaway:** KLAC has delivered stellar returns recently but at a much higher risk profile. The jump in beta suggests the stock is more sensitive to market swings.

## 2ï¸âƒ£ Shortâ€‘Term Price Dynamics  
- **Current price**: **$1,400** â€“ a **+5.69â€¯%** jump from yesterday.  
- **5â€‘day SMA** ($1,366) < current price â†’ **upward momentum**.  
- **20â€‘day SMA** ($1,272) < current price â†’ **strong trend**.  
- **60â€‘day SMA** ($1,207) < current price â†’ **sustained rally**.  

> **Implication:** The price is above all shortâ€‘term averages, signaling a bullish stance in the near term.

## 3ï¸âƒ£ Technical & Risk Indicators  
| Indicator | Value | Interpretation |
|-----------|-------|----------------|
| RSI | 69.85 | Near overbought â€“ could see a pullback. |
| PPO | +0.82â€¯% | Positive momentum. |
| MRI | 0.70 | **Medium risk** â€“ moderate caution advised. |
| Delta Prev Rel Divergence | 0.0 | No change in recent divergence trend. |
| 7â€‘day Rank | +6 | Rank improved â€“ relative strength is rising. |
| 7â€‘day Dyn. Exp. Return | 0.0 | Flat â€“ no immediate change expected. |
| Expected Return | +6.9â€¯% | Longâ€‘term excess vs. S&Pâ€¯500. |

> **Bottom line:** KLAC shows strong momentum but the RSI suggests a possible shortâ€‘term correction. MRI flags medium risk, so a balanced approach is advised.

## 4ï¸âƒ£ News & Events (Top Headlines)  
- **Decâ€¯19,â€¯2025** â€“ Forbes: â€œHow You Can Get 11% Yield On KLAC Stock?â€  
- **Janâ€¯09,â€¯2026** â€“ Bitget: â€œKLA Corporation Stock Soars, Key Info to Know.â€  
- **Decâ€¯22,â€¯2025** â€“ Yahoo Finance: â€œJefferies Upgrades KLA to Buy â€“ Run Just Beginning.â€  
- **Janâ€¯07,â€¯2026** â€“ TechStockÂ²: â€œKLA Hits 52â€‘Week High After Cantor Upgrade.â€  
- **Janâ€¯09,â€¯2026** â€“ MSN: â€œKLA Shares Skyrocket â€“ What You Need to Know.â€  
- **Janâ€¯06,â€¯2026** â€“ Zacks: â€œKLA Jumps 96% in a Year â€“ Is There More Room?â€

> **Insight:** Consistent upgrades and positive media coverage reinforce bullish sentiment. The surge in January 2026 highlights heightened investor interest and potential momentum carryâ€‘over.

## 4â€‘2ï¸âƒ£ Analyst Consensus  
- **Consensus**: **Buy**  
- **Mean Rating**: 2.21 (Buy)  
- **Opinions**: 27 analysts  
- **Target Prices**:  
  - Avg: **$1,330.22**  
  - High: **$1,750.00**  
  - Low: **$1,000.00**  
- **Recent Rating Changes**: No significant updates noted.

> **Takeaway:** Analysts are generally positive, but targets show a wide range, suggesting room for upside.

## 5ï¸âƒ£ Earnings Snapshot  
| Quarter | EPS | Revenue |
|---------|-----|---------|
| 2025â€‘10â€‘31 | 8.51 | $3.21â€¯B |
| 2025â€‘05â€‘01 | 8.21 | $3.06â€¯B |
| 2025â€‘01â€‘31 | 6.18 | $3.08â€¯B |
| 2024â€‘10â€‘31 | 7.05 | $2.84â€¯B |
| 2025â€‘10â€‘31 | 7.05 | $2.84â€¯B |

**Analysis:**  
- EPS growth is robust, especially in the last quarter (8.51 vs. 7.05).  
- Revenue shows steady expansion, hitting a $3.2â€¯B peak.  
- Seasonality appears favorable, with Q4 typically stronger.

## 6ï¸âƒ£ Financial Strength (Q3â€‘2025 Onwards)  
- **Revenue**: $3.21â€¯B â†’ $3.17â€¯B â†’ $3.06â€¯B â†’ $3.08â€¯B â†’ $2.84â€¯B  
- **Profit Margin**: ~61â€¯% (consistent above 60â€¯%).  
- **Equity**: $4.99â€¯B â†’ $4.69â€¯B â†’ $4.00â€¯B â†’ $3.58â€¯B â†’ $3.56â€¯B  
- **ROE**: 22.5â€¯% â†’ 25.6â€¯% â†’ 27.2â€¯% â†’ 23.0â€¯% â†’ 26.6â€¯%  

**Observations:**  
- High margins (~60â€¯%) indicate strong pricing power and cost control.  
- ROE remains solid, peaking above 27â€¯% in Q3â€‘2025.  
- Equity is stable; no sharp dilution.

## 7ï¸âƒ£ Summary & Actionable Takeaways  
- **Performance:** KLAC has outperformed VOO by a wide margin (+106.7â€¯%) and sits at the top of its historical divergence range.  
- **Riskâ€‘Reward:** Alpha is excellent, but beta is very high (160). The stock is a highâ€‘volatility play.  
- **Momentum:** Price is above all moving averages and PPO is positive, but RSI near 70 warns of a potential shortâ€‘term pullback.  
- **Fundamentals:** Revenue, profit margin, and ROE are robust and growing. EPS growth is strong.  
- **Sentiment:** Multiple upgrades and positive news, with analysts in general agreement to buy.  
- **Target Range:** $1,330â€“$1,750, suggesting upside potential if the rally continues.

**Recommendation:**  
- For **shortâ€‘term traders**: Watch RSI; consider taking profits if price pulls below the 20â€‘day SMA.  
- For **longâ€‘term holders**: Medium risk but strong fundamentals and high expected longâ€‘term excess return (6.9â€¯%). A disciplined entry point near the 20â€‘day SMA with a trailing stop could capture upside while limiting downside.  

**Final thought:** KLAC remains a compelling growth play, but its high beta and nearâ€‘overbought RSI call for careful risk management.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.